| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/28/2007 | EP1767541A1 Hla-a24- or hla-a2-binding peptide of parathyroid hormone-related protein |
| 03/28/2007 | EP1767216A1 Drug having regulatory cell ligand contained in liposome |
| 03/28/2007 | EP1767214A1 Use of neurotrophil activating protein of helicobacter pylori (HP-NAP) and/or of its portions as adjuvants for the development of T helper type 1 (TH1) immune responses |
| 03/28/2007 | EP1767196A2 Highly efficient delivery of a large therapeutic mass aerosol |
| 03/28/2007 | EP1766406A2 Anti-cancer activity of an anti-thymidine kinase monoclonal antibody |
| 03/28/2007 | EP1766396A2 Method of passive immunization against disease or disorder characterized by amyloid aggregation with diminished risk of neuroinflammation |
| 03/28/2007 | EP1766393A2 Mhc bridging system for detecting ctl-mediated lysis of antigen presenting cells |
| 03/28/2007 | EP1766391A1 Novel methods of diagnosis of treatment of p. aeruginosa infection and reagents therefor |
| 03/28/2007 | EP1766097A2 Hiv-1 neutralizing antibodies elicited by trimeric hiv-1 envelope glycoprotein complex |
| 03/28/2007 | EP1766094A2 Influenza virus vaccine composition and method of use |
| 03/28/2007 | EP1766093A2 Antibodies against clostridium difficile toxins and uses thereof |
| 03/28/2007 | EP1766059A2 Influenza hemagglutinin and neuraminidase variants |
| 03/28/2007 | EP1766042A2 Diagnostics and therapeutics for diseases associated with chymase (cma1) |
| 03/28/2007 | EP1766034A2 Alphavirus vectors for respiratory pathogen vaccines |
| 03/28/2007 | EP1766017A1 Tumor specific antibody |
| 03/28/2007 | EP1766008A1 Phage screening assay |
| 03/28/2007 | EP1765990A1 Therapeutic, prophylactic and diagnostic agents for hepatitis b |
| 03/28/2007 | EP1765988A2 Novel artificial antigen presenting cells and uses therefor |
| 03/28/2007 | EP1765984A2 Novel cancer cell lines and uses thereof |
| 03/28/2007 | EP1765873A1 Methods and compositions using cd3 agonists |
| 03/28/2007 | EP1765871A1 N-glycosylated antibody |
| 03/28/2007 | EP1765869A1 Antigen binding proteins directed against scavenger receptor b1 that inhibit hcv replication |
| 03/28/2007 | EP1765868A2 Transferrin receptor antibodies |
| 03/28/2007 | EP1765862A2 Heparin binding peptide |
| 03/28/2007 | EP1765855A1 Recombinant rsv strains with altered g protein |
| 03/28/2007 | EP1765433A1 Plasma detoxification and volume control system and methods of use |
| 03/28/2007 | EP1765403A2 Combined active and passive targeting of biologically active agents |
| 03/28/2007 | EP1765402A2 Methods and compositions for enhancement of immunity by in vivo depletion of immunosuppressive cell activity |
| 03/28/2007 | EP1765401A2 Antibodies against human interleukin-13 and uses therefor |
| 03/28/2007 | EP1765400A2 Method for treating lupus |
| 03/28/2007 | EP1765399A1 Combination therapy with radiolabeled anti-cd20 antibody in the treatment of b-cell lymphoma |
| 03/28/2007 | EP1765398A2 Human antibodies interacting with hiv gp41 |
| 03/28/2007 | EP1765397A2 LIGANDS BINDING THE COMPLEX OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (uPA) AND ITS RECEPTOR (uPAR) THAT INHIBIT DOWNSTREAM uPAR INTERACTIONS: IDENTIFICATION AND USE IN DIAGNOSIS OR THERAPY |
| 03/28/2007 | EP1765396A2 Antibodies |
| 03/28/2007 | EP1765395A1 Anti-gluten egg yolk antibodies for the treatment of celiac disease |
| 03/28/2007 | EP1765394A1 Methods for preparing immunogenic conjugates |
| 03/28/2007 | EP1765393A1 Method of enhancing the effect of anti cancer drug by inhibition of the activity of ampk |
| 03/28/2007 | EP1765392A2 Apoptosis-inducing polypeptides |
| 03/28/2007 | EP1765391A1 Bacterial compositions for the treatment of cancer |
| 03/28/2007 | EP1765390A2 Method for preventing and treating alzheimer´s disease |
| 03/28/2007 | EP1765388A2 Combination therapy for preventing or treating alzheimer's disease, and kit therefor |
| 03/28/2007 | EP1765387A2 NEEDLE-FREE ADMINISTRATION OF FeLV VACCINES |
| 03/28/2007 | EP1765386A2 Truncated hepatitis c virus ns5 domain and fusion proteins comprising same |
| 03/28/2007 | EP1765385A1 Sustained release vaccine composition |
| 03/28/2007 | EP1765344A2 Cancer treatment method |
| 03/28/2007 | EP1765328A1 Anti-cancer composition comprising proline or its derivatives and an anti-tumour antibody |
| 03/28/2007 | EP1765312A2 Treatment of diseases associated with the use of antibiotics |
| 03/28/2007 | EP1765294A1 Nucleic acid microspheres, production and delivery thereof |
| 03/28/2007 | EP1765289A2 Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids |
| 03/28/2007 | EP1554305B1 Prion protein-binding peptide sequences |
| 03/28/2007 | EP1416958B1 Vaccine composition comprising at least two valences, one enhanced with adjuvant and not the other |
| 03/28/2007 | EP1403371B1 Polypeptide having a cell death inhibitory activity |
| 03/28/2007 | EP1229933B1 Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof |
| 03/28/2007 | EP1064947B1 In ovo vaccination of marek's disease virus type 1 |
| 03/28/2007 | EP1059089B1 Preventives/remedies for inflammatory intestinal disease |
| 03/28/2007 | EP1010759B1 Non-b non-c non-g hepatitis virus gene, polynucleotide, polypeptide, virion, method for separating virion, and method for detecting virus |
| 03/28/2007 | EP0991426B2 Method for transferring nucleic acid into the striated muscle |
| 03/28/2007 | CN1938047A Methods of treating hemolytic anemia |
| 03/28/2007 | CN1938046A Monomethylvaline compounds capable of conjugation to ligands |
| 03/28/2007 | CN1938045A Methods of therapy for solid tumors expressing the cd40 cell-surface antigen |
| 03/28/2007 | CN1938044A Yeast-based vaccines as immunotherapy |
| 03/28/2007 | CN1938040A Oxytocin controlled release formulations and methods of using same |
| 03/28/2007 | CN1938025A Angiogenesis-affecting compounds and methods of use thereof |
| 03/28/2007 | CN1936007A Anti H5N1 highly pathogenic avian influenza virus antisense oligonucleotide structure and its use |
| 03/28/2007 | CN1935262A Use of red Nocardia cyto skeleton for preparing anti human papillomavirus medicine |
| 03/28/2007 | CN1935261A Medicine composition for preventing and treating diabetes mellitus and its use |
| 03/28/2007 | CN1935260A Human antibodies that bind human tnfalpha |
| 03/28/2007 | CN1935259A Ultrasonic microvesicle as immuno adjuvant and vaccine carrier |
| 03/28/2007 | CN1935258A West nile vaccine |
| 03/28/2007 | CN1307308C Nucleotide specific for Escherichia coli 085-type O-antigen |
| 03/28/2007 | CN1307307C Nucleotide specific for Shigella bogdii B14-type O-antigen |
| 03/28/2007 | CN1307306C Nucleotide specific for Escherichia coli 011-type O-antigen |
| 03/28/2007 | CN1307201C Coupled substance between Lidamycin and segments of monoclonal antibody 3G11, 3G11Fab' |
| 03/28/2007 | CN1307196C Modified CpG oligodeoxynucleotide with improved immunoregulatory function |
| 03/28/2007 | CN1306963C Remedy for diseases caused by IL-6 production |
| 03/28/2007 | CN1306962C Canine distemper virus separated in korea and recombinant vaccine therefrom |
| 03/28/2007 | CN1306961C Preparation of tetravalent wheel shaped virus inactivated vaccine and application |
| 03/28/2007 | CN1306960C Curtail hemagglutinin vaccine for preventing influenza virus and its preparing method |
| 03/28/2007 | CN1306959C Process for preparing subunit vaccine of reovirus antigen for grass carp |
| 03/28/2007 | CN1306958C Glycoconjugate vaccines for use in immune-compromised populations |
| 03/28/2007 | CN1306957C Anti infantile diarrhoed pathogenic bacteria immune milk product and its production method |
| 03/28/2007 | CN1306956C Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies |
| 03/27/2007 | US7196188 Methods and compositions for screening of human borna disease virus |
| 03/27/2007 | US7196186 Plasmid comprising nucleotide sequences coding antigenic proteins for use in prevention and treatment of infectious and neoplastic diseases; gene therapy |
| 03/27/2007 | US7196181 made in non-thyroidal eukaryotic cells; for diagnosis and treatment of immune disorders such as Hashimoto's thyroiditis |
| 03/27/2007 | US7196175 Antibodies to JTT-1 protein and cells secreting such antibodies |
| 03/27/2007 | US7196073 polysaccharide binding to surface receptor on antigen presenting cells |
| 03/27/2007 | US7196058 Method of treatment of conditions by administration of streptolysin O |
| 03/27/2007 | US7195926 preparing polyclonal antibodies by immunizing animals with polypeptides under conditions to elicit an antibody response and screening the resultant antigens with the polypeptide to identifying polyclonal antibodies which bind specifically to the polypeptide |
| 03/27/2007 | US7195911 Mammalian cells that have increased proliferative capacity |
| 03/27/2007 | US7195905 Enveloped virus vaccine and method for production |
| 03/27/2007 | US7195903 Comprises metallloenzyme which is fibrinolytically active (fibrolase), for use in treating blood clots in situ |
| 03/27/2007 | US7195774 Surgically implantable and sealable drug delivery device that upon contact of its contents via an interface window or port with an organ or tissue exposes a therapeutic agent to organ or tissue surface, allowing a controlled, selective diffusion |
| 03/27/2007 | US7195768 Polyvalent immunogen |
| 03/27/2007 | US7195767 Method to detect IgE |
| 03/27/2007 | US7195765 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
| 03/27/2007 | US7195764 Cancerous disease modifying antibodies |
| 03/27/2007 | US7195763 Treating or preventing infections; polyclonal and monoclonal antibodies |
| 03/27/2007 | US7195762 Density enhanced protein tyrosine phosphatases |
| 03/27/2007 | US7195761 Humanized antibodies that sequester abeta peptide |